Navigation Links
Biocartis Strengthens Management Team With Chief Commercial Officer
Date:9/4/2013

LAUSANNE, Switzerland and MECHELEN, Belgium, September 4, 2013 /PRNewswire/ --


Biocartis, a molecular diagnostics company, announces today that Ulrik Cordes has joined the company as Chief Commercial Officer (CCO). Ulrik Cordes is an executive with 18+ years of experience in marketing and sales in the med-tech, pharma and biotech industry, of which the past 10 years in top level management roles.

"We are delighted to welcome Ulrik to Biocartis' Executive Team," said RudiPauwels, CEO and Chairman  of Biocartis. "We are transforming from a development company into a commercial business. The addition of Ulrik will be key to achieving our ultimate goal to making personalized medicine a day-to- day reality by building a global business. Ulrik possesses a unique combination of experience and success in building winning commercial strategies and attracting world class sales and sales support professionals."

Ulrik Cordes joins Biocartis most recently from Thermo Fisher Scientific, where he held the position of Global Sales & Marketing Director Slides & Specialty Glass since March 2012. Since 2002 Ulrik worked at DAKO A/S - A World-leading Company in Cancer Diagnostics, where he held a number of positions with increasing responsibility, most recently as Vice President Marketing Operations and Vice President Asia Pacific & Export Region.

He started his career in 1995 in Pharmacia Biotech A/S (now part of GE Healthcare). Ulrik received his Master of Science in Biochemistry from the University of Copenhagen and holds a Bachelor of Commerce (HD) from Copenhagen Business School.

About Biocartis (http://www.biocartis.com)
Biocartis aims to improve healthcare outcomes by enabling the practice of personalized medicine anywhere, anytime. Biocartis' ambition is to establish a new gold standard in diagnostic testing. Biocartis' innovative research and diagnostic systems are characterized by multiplex detection and simplified workflows which require less hands-on time and minimize sample requirements (especially for tumor biopsies). Additionally, Biocartis develops assays which have high clinical utility and compelling health economic value. Oncology is the primary focus of Biocartis as this is one of the greatest unmet needs for personalized medicine. Biocartis is well suited to address the growing need for individualized diagnosis and treatment of cancer patients.

Biocartis is a rapidly growing company; to date Biocartis staff includes over 170 people.


'/>"/>
SOURCE Biocartis NV
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Biocartis versterkt managementteam met commercieel directeur
2. CareFusion Strengthens U.K. Presence With Acquisition of Medical Products Distributor
3. Tris Pharma Expands Manufacturing Capacity and Strengthens Supply Chain to Support New and Pending Approvals
4. RxAlly Strengthens Leadership Team With New Chief Information Officer Mike Groh
5. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
6. Actinium Pharmaceuticals Strengthens Management Team
7. Pharmalink AB Strengthens Senior Management Team
8. Jardogs Strengthens Leadership Team with the Addition of Two Seasoned Healthcare Executives
9. inVentiv Health Strengthens Clinical Leadership Team
10. Alliqua Strengthens and Realigns Executive Team
11. Neuland Labs Strengthens Commitment to Japanese Market With New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 2016 The global prefilled syringes market accounted ... expected to grow with a CAGR of 12.9% during ... segment dominated the global prefilled syringes market, with 90.1% ... --> The global market of prefilled syringes is ... geriatric population, increasing demand for vaccines, increasing prevalence of ...
(Date:2/9/2016)... 9, 2016 The life of Dr. Jan ... been anything but ordinary.  Twists of fate, combined with sheer ... and the constraints of communist Czechoslovakia to New ... go on to make history by playing a key role ... in the world, Remicade.  Dr. Vilcek brings readers along his ...
(Date:2/9/2016)... N.J. , Feb. 9, 2016  Bluestar Silicones ... (LSR) product line for long-term implant applications and ... Medical Design & Manufacturing (MD&M) West Conference (Booth ... --> --> ... Silbione® Biomedical LSRs offer outstanding physical properties enabling ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... 09, 2016 , ... Sir Grout, the leading hard surface ... announce that many of their franchises have received the Super Service Award from ... franchises received customer recognition through positive reviews and testimonials, as well as evaluations ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Brain Preservation Foundation’s (BPF) ... from 21st Century Medicine (21CM) ( http://www.21cm.com/ ), spearheaded by recent MIT ... of an intact rabbit brain for extremely long-term storage using a combination of ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... Nutrition into the Food & Beverage and Dietary Supplement ... partner throughout Canada and USA geographies east of the Rocky Mountains since 2012. ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Valentine’s Season is famous for gift giving with flowers, chocolates ... they are loved. This year, for more than 5.6 million Americans suffering with Alzheimer’s, ... be enough to remind them of the lives they’ve led and the people they’ve touched. ...
(Date:2/8/2016)... York, NY (PRWEB) , ... February 08, 2016 , ... ... are too much to handle, you are not alone. According to the Center for ... include heart disease, stroke, type 2 diabetes and certain types of cancer, some of ...
Breaking Medicine News(10 mins):